Protagonist Stock 120%, Fund Outlook and Exit Signals
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
This piece explains how wash sale rules affect Dividend Etf losses, with practical strategies to stay compliant and preserve tax benefits.
20,231 articlesA hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
The passing of a long-time CEO marks a watershed moment for any company. This guide helps investors evaluate Simon Pr...
An AI forecast from Claude points to multix gains for XRP, Solana, and Dogecoin by 2026. The predictions hinge on ado...
SpaceX finally going public would rewrite who can own a piece of the rocket company. This guide breaks down the IPO b...
The GraniteShares 2x Long NVDA Daily ETF has sparked investor interest with a strong start to 2026, only to face a sh...
A SpaceX AI model tied to Elon Musk forecasts a 30-day Bitcoin rally, even as the market hesitates near $63,000. Anal...
A historic IPO sparked a wave of leveraged ETFs designed to amplify daily moves. This report breaks down how they wor...
Quantum computing stocks moved lower in Monday trading as investors rotated into safer assets amid a broader tech mar...
A high-yield ETF promises sky-high payouts but posted negative returns over the last year as investors weigh the true...
The latest nationwide data reveal a 7.6% drop in new foreclosure filings, but a closer look shows pockets of rising d...
A major fund recently trimmed its stake in Viridian Therapeutics, signaling potential rotation rather than a verdict ...
A tiny $3.7 million exit can mask broader gains in regional bank stocks. This article breaks down what that signal re...